JP2023542241A5 - - Google Patents

Info

Publication number
JP2023542241A5
JP2023542241A5 JP2023524498A JP2023524498A JP2023542241A5 JP 2023542241 A5 JP2023542241 A5 JP 2023542241A5 JP 2023524498 A JP2023524498 A JP 2023524498A JP 2023524498 A JP2023524498 A JP 2023524498A JP 2023542241 A5 JP2023542241 A5 JP 2023542241A5
Authority
JP
Japan
Prior art keywords
seq
polynucleotide
vector
expression cassette
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023524498A
Other languages
English (en)
Japanese (ja)
Other versions
JP7837963B2 (ja
JP2023542241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040366 external-priority patent/WO2022006551A2/en
Publication of JP2023542241A publication Critical patent/JP2023542241A/ja
Publication of JP2023542241A5 publication Critical patent/JP2023542241A5/ja
Priority to JP2025256145A priority Critical patent/JP2026034616A/ja
Application granted granted Critical
Publication of JP7837963B2 publication Critical patent/JP7837963B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023524498A 2020-07-03 2021-07-02 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸 Active JP7837963B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025256145A JP2026034616A (ja) 2020-07-03 2025-12-16 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063047965P 2020-07-03 2020-07-03
US63/047,965 2020-07-03
US202063054162P 2020-07-20 2020-07-20
US63/054,162 2020-07-20
US202063067264P 2020-08-18 2020-08-18
US63/067,264 2020-08-18
US202163141918P 2021-01-26 2021-01-26
US63/141,918 2021-01-26
US202163188778P 2021-05-14 2021-05-14
US63/188,778 2021-05-14
PCT/US2021/040366 WO2022006551A2 (en) 2020-07-03 2021-07-02 Modified insulin and glucokinase nucleic acids for treating diabetes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025256145A Division JP2026034616A (ja) 2020-07-03 2025-12-16 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸

Publications (3)

Publication Number Publication Date
JP2023542241A JP2023542241A (ja) 2023-10-05
JP2023542241A5 true JP2023542241A5 (https=) 2024-07-10
JP7837963B2 JP7837963B2 (ja) 2026-03-31

Family

ID=79317842

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023524498A Active JP7837963B2 (ja) 2020-07-03 2021-07-02 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸
JP2025256145A Pending JP2026034616A (ja) 2020-07-03 2025-12-16 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025256145A Pending JP2026034616A (ja) 2020-07-03 2025-12-16 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸

Country Status (10)

Country Link
US (1) US20240279300A1 (https=)
EP (1) EP4176060A4 (https=)
JP (2) JP7837963B2 (https=)
KR (1) KR20230087436A (https=)
CN (1) CN116234904A (https=)
AU (1) AU2021300450A1 (https=)
CA (1) CA3174156A1 (https=)
IL (1) IL299545A (https=)
MX (1) MX2023000099A (https=)
WO (1) WO2022006551A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023259404A1 (en) * 2022-04-29 2024-11-28 Kriya Therapeutics, Inc. Insulin and glucokinase gene therapy compositions and its use for treating diabetes
AU2024370040A1 (en) * 2023-11-01 2026-04-23 Kriya Therapeutics, Inc. Aav mediated insulin and glucokinase gene therapy for treating diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1633876T3 (pl) * 2003-06-17 2009-01-30 Sembiosys Genetics Inc Sposoby wytwarzania insuliny w roślinach
EP2605798A1 (en) * 2010-07-12 2013-06-26 Universidad Autònoma de Barcelona Gene therapy composition for use in diabetes treatment
US11033638B2 (en) * 2015-01-07 2021-06-15 Universität Autonoma De Barcelona Single-vector gene construct comprising insulin and glucokinase genes

Similar Documents

Publication Publication Date Title
US20220331409A1 (en) Factor ix gene therapy
JP2022544004A (ja) 操作された核酸調節エレメントならびにその使用方法
RU2021102893A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
US20040087028A1 (en) Ecdysone-inducible adeno-associated virus expression vectors
CN108368521A (zh) Glp-1和其在用于治疗代谢疾病的组合物中的用途
JP2020520643A5 (https=)
JP2022541070A5 (https=)
WO2003059396A1 (en) Adiponectin gene therapy
EP4230733A1 (en) Mini-gde for the treatment of glycogen storage disease iii
JP2023509443A5 (https=)
EP3344650B1 (en) Aav-epo for treating companion animals
JP2023539247A (ja) Ｇｌｐ－１受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用
JP2023542241A5 (https=)
JP2023543125A (ja) Ｇｌｐ－１受容体アゴニスト融合物をコードするウイルスベクター及び代謝性疾患の治療におけるその使用
JP2025508987A (ja) Ｇｌｐ－１受容体アゴニスト融合物の送達のためのａａｖベクター
JP2025508981A (ja) インスリン融合タンパク質をコードするウイルスベクターゲノム
US20240010699A1 (en) Viral vectors encoding canine insulin for treatment of metabolic diseases in dogs
US20230313152A1 (en) C-terminal truncated gde for the treatment of glycogen storage disease iii
JP2025509193A (ja) Ｇｌｐ－２受容体アゴニスト融合物をコードするウイルスベクター及び短腸症候群の治療におけるその使用
JP2025515030A5 (https=)
WO2025162449A1 (en) Compositions and methods for the treatment of heart disease
JP2025508988A (ja) 副甲状腺ホルモン融合物をコードするウイルスベクター及び副甲状腺機能低下症の治療におけるその使用
JP2023543356A (ja) 組成物およびその使用
JP2024517737A5 (https=)
HK40097433A (en) Mini-gde for the treatment of glycogen storage disease iii